Incremental value of carotid intraplaque hemorrhage for discriminating prior coronary events by unknown
RESEARCH ARTICLE Open Access
Incremental value of carotid intraplaque
hemorrhage for discriminating prior coronary
events
Jie Sun1*, Daniel S. Hippe1, Hunter R. Underhill2, Baocheng Chu1, Tobias Saam3, Norihide Takaya4, Jianming Cai5,
Minako Oikawa-Wakayama6, Wei Yu7, Li Dong7, Chun Yuan1 and Thomas S. Hatsukami8*
Abstract
Background: The value of noninvasive assessment of carotid plaque composition in identifying patients with high
coronary risk remains elusive. We sought to determine whether and which carotid plaque components are associated
with prior coronary events independent of traditional risk factors and plaque burden.
Methods: Asymptomatic subjects with 50-79 % carotid stenosis by ultrasound were imaged with a multi-contrast carotid
MRI protocol at 1.5 T. The independent associations between plaque components (fibrous tissue, calcification, lipid-rich
necrotic core [LRNC] and intraplaque hemorrhage [IPH]) and prior coronary events, including myocardial infarction and
coronary revascularization, were evaluated by controlling for traditional risk factors and plaque burden metrics.
Results: A total of 159 subjects (69.7 ± 9.0 years, 84 % males) were included. Prior coronary events were documented in
66 (42 %) subjects, and were associated with a larger carotid plaque burden consisting of more LRNC and calcification.
Additionally, a higher prevalence of IPH was observed in subjects with prior coronary events (32 % vs. 15 %, p = 0.019).
In multivariate analysis, the percent wall volume was an independent discriminator among plaque burden metrics after
accounting for traditional risk factors (odds ratio per 1-SD increase: 1.7 [1.2, 2.6]); the presence of IPH remained as a
significant discriminator after accounting for traditional risk factors and percent wall volume (odds ratio: 2.9 [1.1, 7.6])
while other compositional metrics did not.
Conclusions: IPH in the carotid artery was independently associated with prior coronary events. IPH imaging may
provide incremental information on patients’ coronary risk beyond traditional risk factors and carotid plaque burden
assessment.
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Background
Because of the systemic nature of atherosclerosis, sub-
clinical carotid disease has long been used as a surrogate
of coronary artery disease (CAD). Measurements on ca-
rotid plaque burden have been shown to predict the ex-
tent and clinical risk of underlying CAD [1–4], whereas
the value of carotid plaque composition, although widely
believed to indicate lesion instability, remains elusive for
the evaluation of CAD risk.
Assessment of carotid plaque composition has been
available via noninvasive imaging, which potentially can
provide clinicians with incremental information on pa-
tients’ coronary risk. Recently, the echolucent carotid
plaques by ultrasound [5] and those with high-intensity
signals by T1-weighted magnetic resonance imaging
(MRI) [6] were shown to predict future coronary events
independent of clinical risk factors. However, compos-
itional features are known to have positive relationships
with plaque burden [7, 8], and their added value will
not be clear unless tested against plaque morphological
metrics.
In this study, we sought to test whether and which ca-
rotid plaque compositional metrics confer incremental
values for discriminating prior coronary events in
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subjects with subclinical carotid disease. While all sub-
jects in this study had imaging evidence of atheroscler-
osis, those with prior coronary events were considered
to be at a much higher risk for future events [9]. We hy-
pothesized that specific markers on carotid plaque com-
position could help identify subjects with prior coronary
events and thus serve as novel markers for vulnerable
patients. Carotid MRI provides comprehensive plaque
morphological measurements, and is a validated tool for
detecting major plaque components in vivo [10–12].
Methods
Study population
Subjects in a previously-established cohort were included
in this retrospective study [13]. Briefly, asymptomatic
subjects with substantial carotid plaques were recruited
in this exploratory study to include a wide spectrum of
compositional phenotypes. Specific criteria were: 1) 50-
79 % stenosis by duplex ultrasound in at least one ca-
rotid artery; 2) neurologically asymptomatic defined as
no cerebrovascular symptoms in the 6 months prior to
enrollment; 3) no prior carotid endarterectomy (CEA),
neck radiation or contraindications for MRI (e.g. metal
implants, claustrophobia). Enrolled subjects completed
a standardized health questionnaire covering demograph-
ics and cardiovascular risk factors (smoking, hypertension,
hypercholesterolemia, and diabetes mellitus) [13]. Smok-
ing was self-reported and included former smoking
and current smoking. Hypertension was defined as sys-
tolic blood pressure ≥ 140 mmHg and/or diastolic blood
pressure ≥ 90 mmHg, or taking anti-hypertensive agents.
Diabetes was defined as previously confirmed diagnosis
and/or use of anti-diabetic agents. Hypercholesterolemia
was defined as a history of total cholesterol > 5 mmol/l
and/or low-density lipoprotein cholesterol (LDL-C) >
3 mmol/l, or taking lipid-lowering medications. Prior
coronary events were collected and verified by chart re-
view. A positive history of coronary events was defined
as having one or more of the following events: 1)
hospitalization for myocardial infarction; 2) coronary
revascularization including angioplasty, stenting and
coronary artery bypass graft (CABG). All study proce-
dures were reviewed and approved by the institutional
review board. Subjects provided informed consent be-
fore enrollment.
MRI Protocol
All scans were performed on a 1.5 T scanner (Signa
Horizon EchoSpeed, GE Healthcare, Milwaukee, Wisconsin,
USA) using phased-array surface coils (Pathway, Seattle,
Washington, USA). A previously published standardized
protocol [14, 15] was used to acquire cross-sectional,
multi-contrast images (3-dimensional time-of-flight [TOF],
T1-weighted, proton density-weighted [PD], and T2-
weighted) that were centered at the carotid bifurcation
of the side with 50-79 % stenosis. No contrast agent was
used to increase patient recruitment and compliance.
Previous studies have shown that this non-contrast
protocol was able to characterize major plaque compo-
nents [10, 13]. All images were obtained with field-of-
view of 13 to 16 cm, matrix size of 256 × 256, and slice
thickness of 2 mm. Scan coverage was 40 mm for TOF,
20–24 mm for T1-weighted, and 30 mm for proton
density-weighted and T2-weighted sequences. Total ac-
quisition time was approximately 30 min.
Image analysis
Eight reviewers with at least 1-year experience in MR
plaque imaging participated in image analysis while
blinded to clinical data using a custom-designed image
analysis software package (CASCADE, University of
Washington, Seattle, Washington, USA) [16]. Only the
index artery, defined as the side with 50-70 % stenosis
by ultrasound, was analyzed. The four contrast weight-
ings (TOF, T1, PD, and T2) were registered using the
carotid bifurcation as a landmark. Lumen and outer wall
boundaries were outlined on each cross-sectional slice as
well as plaque components that were determined using
previous published criteria (Figure 1) [10, 12]. Briefly, cal-
cification appears hypointense on all weightings; intrapla-
que hemorrhage (IPH) appears hyperintense on TOF and
T1-weighted images; lipid-rich necrotic core (LRNC) usu-
ally appears hypointense on T2- and PD-weighted images
but may have variations if it contains IPH [12]. Remaining
wall areas were classified as fibrous tissue. Subsequently,
maximum wall thickness, maximum percent wall area
(100 % ×wall area/total vessel area), percent wall volume
(100 % ×wall volume/total vessel volume), were calcu-
lated. Percent volumes of calcification and LRNC and the
presence/absence of IPH were also calculated and/or re-
corded. All imaging data were based on consensus opinion
of at least two reviewers.
Statistical analysis
All data are presented as mean ± standard deviation (SD)
for continuous variables and count with percentage for
categorical variables. Subjects were stratified according
to a positive or negative history of prior coronary events.
Clinical and imaging characteristics were compared
between the two groups using the independent t-test,
Mann–Whitney test, and Fisher’s exact test, as appropriate.
The incremental values of: 1) carotid plaque morphological
metrics over clinical variables; and 2) compositional met-
rics over clinical variables and morphological metrics, for
discriminating prior coronary events, were examined using
multivariate logistic regression analysis and presented as
odds ratios (OR) with 95 % confidence interval (CI). To
examine the influence of plaque burden on the ability of
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compositional metrics for discriminating prior coronary
events, interactions between plaque morphological and
compositional metrics were also tested. All data analyses
were performed using R 2.15.2 (R Foundation for Statistical
Computing, Vienna, Austria). Statistical significance was
defined as P < 0.05.
Results
Clinical and imaging characteristics
Table 1 summarizes the clinical and imaging characteris-
tics of the study population (N = 159). Prior coronary
events were documented in 66 (42 %) subjects. Com-
pared to subjects without prior coronary events, those
with prior coronary events had a higher prevalence of
hypercholesterolemia (92 % vs. 70 %, p = 0.001), and
were more frequently on statin therapy (82 % vs. 52 %,
p < 0.001), but otherwise had similar clinical profiles
(Table 1). Observed differences in carotid plaques in-
cluded larger plaques, less fibrous tissue, and a higher
prevalence of IPH in subjects with prior coronary events
(Table 1).
Incremental value of carotid plaque morphology
All three morphological metrics of plaque burden were
significantly associated with prior coronary events (Table 2).
Fig. 1 Carotid plaque burden and composition detected by combined use of multiple MR weightings at 1.5 T. Arrows indicate lipid-rich necrotic
core as hypointense areas on T2W images. Arrowheads indicate intraplaque hemorrhage as hyperintense areas on TOF images. PDW = proton-
density-weighted; T1W = T1-weighted; T2W = T2-weighted; TOF = time-of-flight
Table 1 Clinical and imaging characteristics stratified by history







Age, years 69.3 ± 8.9 70.2 ± 9.2 0.52
Male sex 75 (81) 59 (89) 0.19
Smoker 79 (85) 61 (92) 0.22
Hypertension 68 (73) 54 (82) 0.25
Hypercholesterolemia 65 (70) 61 (92) 0.001
Diabetes mellitus 25 (27) 18 (27) 0.99
Statin use 48 (52) 54 (82) <0.001
Imaging characteristics
Maximum wall thickness, mm 4.1 ± 1.4 4.6 ± 1.7 0.035
Maximum percent wall area 71.5 ± 13.4 76.0 ± 11.0 0.028
Percent wall volume 60.2 ± 10.1 65.4 ± 8.9 0.003
% calcification 3.9 ± 5.0 5.5 ± 6.5 0.098
% lipid-rich necrotic core 9.2 ± 11.1 12.8 ± 12.6 0.13
% fibrous tissue 84.6 ± 11.0 78.7 ± 11.9 0.003
Presence of IPH 14 (15) 21 (32) 0.019
Data are presented as mean ± SD or count (percentage)
% = percent volume; IPH = intraplaque hemorrhage; SD = standard deviation
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The OR for prior coronary events ranged from 1.4 to 1.8
per 1-SD increase in maximum wall thickness, maximum
percent wall area, and percent wall volume. Percent wall
volume not only appeared to be the strongest discriminator
amongst the plaque morphological metrics for prior coron-
ary events, but also remained significant after adjusting for
demographics and clinical risk factors (OR: 1.7 [1.2, 2.6]
per 1-SD increase, p = 0.005).
Incremental value of carotid plaque composition
Among carotid plaque compositional metrics, a lower
percent volume of fibrous tissue and presence of IPH
were associated with a positive history of coronary events
(Table 3). After adjusting for clinical risk factors, as well
as percent wall volume, the presence of IPH remained
as a significant discriminator for prior coronary events
(OR: 2.9 [1.1, 7.6], p = 0.033).
Plaque burden did not appear to influence the ability
of IPH to discriminate subjects with prior coronary events
(p-value ranged from 0.40 to 0.99 for interactions). Fig. 2
shows the association between IPH and prior coronary
events in different subgroups defined by carotid plaque
morphological metrics. Of note, all subjects in the lower
half of maximum wall thickness and with IPH had prior
coronary events.
Discussion
By using carotid MRI, we were able to evaluate and com-
pare carotid plaque morphological and compositional
metrics in relation to coronary plaque vulnerability, de-
fined as having prior coronary events in this study. The
most pronounced difference in carotid plaque morphology
between subjects with and without prior coronary events
was shown in percent wall volume. Furthermore, the
incremental value of carotid plaque composition for dis-
criminating prior coronary events, specifically the pres-
ence of IPH, was demonstrated by accounting for
clinical risk factors as well as percent wall volume. In
addition to some pathophysiological insights, our find-
ings indicate that a combination of three-dimensional
plaque characterization and IPH detection in the assess-
ment of subclinical carotid atherosclerosis may offer the
most promising information on patients’ coronary risk.
Carotid plaque detection by B-mode ultrasound has
been shown to improve individual risk assessment com-
pared to the intima-media thickness [4]. The introduc-
tion of novel ultrasound techniques provides additional
opportunities to optimize this approach through improved
plaque characterization [17, 18]. This concept is further
supported by autopsy findings showing that vulnerable
features tend to be present at multiple arterial beds within
the same individual [19, 20]. To determine what informa-
tion embedded in carotid plaque tissue composition are
relevant to coronary risk, we used carotid MRI to compare
carotid plaque compositional metrics between subjects
with and without prior coronary events. Carotid MRI
gives a comprehensive assessment of local plaque burden
by capturing both luminal stenosis and outward remodel-
ing. Additionally, combining MRI contrast weightings has
been shown to be able to characterize plaque components
[10, 11]. Therefore, multiple morphological and compos-
itional metrics can be compared head-to-head in a single
study.
The presence of IPH in the carotid artery was found
to be an additional indicator for coronary vulnerability,
with an odds ratio of 2.9 (95 % CI: 1.1-7.6) for prior cor-
onary events after adjustment for clinical variables and
percent wall volume. The observation is consistent with
a previous histopathological study by Hellings et al. [21]
in which carotid IPH identified by post-surgical examin-
ation of carotid endarterectomy specimens was associated
with systemic cardiovascular outcomes. It was noted
that the observed relationship between carotid IPH and
Table 2 Associations between carotid plaque morphological metrics and prior coronary events
Unadjusted Adjustedb
OR (95 % CI)a p value OR (95 % CI)a p value
Maximum wall thickness 1.4 (1.0, 2.0) 0.034 1.4 (1.0, 2.0) 0.092
Maximum percent wall area 1.4 (1.0, 2.0) 0.030 1.4 (0.9, 1.9) 0.105
Percent wall volume 1.8 (1.2, 2.5) 0.002 1.7 (1.2, 2.6) 0.005
aData are presented as odds ratios per 1-SD higher values
bAdjusted for clinical risk factors (age, gender, smoking status, hypertension, hypercholesterolemia, diabetes mellitus and statin use)
CI = confidence interval; OR = odds ratio; SD = standard deviation
Table 3 Associations between carotid plaque compositional
metrics and prior coronary events
Unadjusted Adjustedb
OR (95 % CI)a p value OR (95 % CI)a p value
% calcification 1.3 (1.0, 1.8) 0.083 1.2 (0.8, 1.7) 0.40
% LRNC 1.4 (1.0, 1.9) 0.052 1.2 (0.8, 1.8) 0.40
% fibrous tissue 0.6 (0.4, 0.8) 0.002 0.7 (0.4, 1.1) 0.13
Presence of IPH 2.6 (1.2, 5.7) 0.014 2.9 (1.1, 7.6) 0.033
aData are presented as odds ratios per 1-SD higher values for continuous
variables
bAdjusted for age, gender, smoking status, hypertension,
hypercholesterolemia, diabetes mellitus, statin use and percent wall volume
% = percent volume; CI = confidence interval; IPH = intraplaque hemorrhage;
OR = odds ratio; SD = standard deviation
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coronary events alone was more marginal (hazard ratio:
1.6, 95 % CI: 0.9-3.0) [21]. Surgical patients have end-
stage plaques and are frequently symptomatic whereas
our study included only asymptomatic subjects with
moderate carotid disease. After stratifying our study popu-
lation by plaque size, there appeared to be no evidence
that the relationship between IPH and prior coronary
events varied in those with high or low plaque burden.
Nonetheless, subjects with IPH but not much wall thick-
ening may represent a unique group for further investi-
gations (Fig. 2). Collectively, existing evidence suggests
clinicians to note the increased coronary risk if IPH is
detected in the carotid artery, particularly in those with
asymptomatic carotid lesions.
In contrast to IPH, other plaque components did not
show incremental discriminative power over plaque mor-
phological assessment. Subjects with prior coronary events
had significantly less fibrous tissue in the carotid plaque,
due to increase in both calcification and lipid core.
However, such an association was largely accounted for
by clinical risk factors and concomitantly larger percent
wall volume.
Natural history studies have revealed that most coron-
ary events were preceded by rapid plaque expansion that
was unusual and unrelated to baseline plaque burden
[22–24]. IPH, with the capability to induce changes in
plaque behavior [25], may play a critical role in the patho-
genesis of coronary events. In a postmortem study, Fleiner
et al. described that the hyperplasia of vasa vasorum was a
systemic feature of symptomatic patients [20]. As adventi-
tial vasa vasorum is a major source of IPH [26], the find-
ing by Fleiner et al. supports the conjecture that carotid
IPH indicates increased probability of coronary IPH. An-
other study by Moreno et al. also sheds light by showing
that genotypes related to hemoglobin clearance may de-
termine one’s susceptibility to IPH-induced detrimental
effects [27]. It is possible that the presence of carotid
IPH by MRI indicates certain genetic vulnerabilities re-
lated to IPH metabolism. Nonetheless, given the limited
understanding of the pathophysiology of IPH in the current
literature, although IPH in the carotid artery appears to in-
dicate additional systemic factors that contribute to plaque
instability, the exact mechanisms remain to be investigated.
Singh et al. [28] also noted a higher prevalence of ca-
rotid IPH in patients with prior coronary events. That
study included subjects referred for carotid MRI due to
suspected neurovascular disease, so the study population
appears to be a mixture of symptomatic and asymptom-
atic subjects. It is conceivable that there would be a wider
range of carotid plaque burden in the previous report
compared to the present data. As IPH is known to be as-
sociated with a larger plaque burden [29], a wider range
of plaque burden in study population makes it difficult
to argue that the observed relationship is not due to the
higher plaque burden associated with IPH but related
to the unique pathophysiology of IPH. In the present
study, by including subjects with similar extent of ca-
rotid disease and quantifying plaque burden in a three-
dimensional fashion, we were able to test the independent
association between carotid IPH and coronary events
rigorously. In this study, plaque morphological measure-
ments were derived from MRI rather than ultrasound
which is more widely used in clinical practice. However,
MRI provides multiple plaque morphological metrics, and
therefore the incremental value of carotid plaque compos-
ition could be rigorously tested. The maximum wall thick-
ness measures plaque burden at a single location. The
maximum percent wall area measures a single slice and
essentially indicates luminal narrowing after taking into
account outward remodeling, which is similar to sten-
osis measurement on black-blood carotid MRI proposed
by Babiarz et al. [30]. The percent wall volume, as a
Fig. 2 Prevalence of prior coronary events in subjects with and without
IPH in subgroups by carotid plaque burden. Subgroups were defined
for each burden metric as being below or above the median value.
IPH = intraplaque hemorrhage; WT = wall thickness
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3-dimensional metric, is similar to the percent atheroma
volume that is used in intravascular ultrasound studies
of coronary vasculature [31]. Among the three morpho-
logical metrics, the percent wall volume was the best
discriminator for prior coronary events, supporting the
pursuit of 3-dimensional carotid plaque characterization
as a future tool in CAD management [32].
Implications
Findings from this study have implications both for un-
derstanding the pathophysiology of vulnerable patients
and for optimizing clinical management in individuals.
Although atherosclerosis becomes highly prevalent as
people get older, certain patients are at a particular high
risk for clinical events. Our data suggest that carotid IPH
was associated with increased risk for coronary events and
the association was not explained by differences in trad-
itional risk factors and plaque burden. Thus, it is conceiv-
able that additional systemic factors that relate to the
pathogenesis of IPH may be the underlying players, such
as the hyperplasia of vasa vasorum and haptoglobin geno-
type [20, 27]. Accordingly, there is potential for using
carotid IPH as a novel marker for high coronary risk in
developing medical treatment strategies, which may in-
clude more stringent treatment goals for lipid-lowering
and anti-hypertensive agents as well as novel agents that
can target IPH and its detrimental effects on plaque
progression.
Study limitations
There are several limitations of the present study. Our
study population is selective in that it only included neuro-
logically asymptomatic subjects with 50-79 % carotid sten-
osis by ultrasound. Despite the relatively narrow range in
stenosis, a wide range in plaque composition was observed
and offered a good opportunity to test the incremental
value of plaque composition in discriminating prior coron-
ary events. However, it remains to be seen whether the in-
dependent association of IPH with coronary events applies
to the general population. Due to the retrospective nature
of the design, patients with severe coronary events such as
coronary death could not be included. We do not expect
this selection bias that is present in most clinical research
to affect our study findings. But the prevalence of carotid
IPH in those with more severe coronary events could be
higher than what was seen in this study. In addition, circu-
lating biomarkers, such as C-reactive protein, which have
been shown to improve risk appraisal in individuals [33],
were not examined in the present study. Therefore, we
could not exclude the possibility that the association
between IPH and coronary events may be mediated by
biomarkers. It is worth mentioning that epidemiological
studies using carotid MRI are still sparse, and no bio-
markers have been linked with IPH to date.
Conclusions
In conclusion, subjects with prior coronary events had a
high prevalence of IPH. The association could not be
explained by differences in traditional risk factors and
plaque burden. IPH may provide incremental informa-
tion on patients’ coronary risk, possibly by indicating
additional systemic factors that contribute to plaque
instability.
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